Philippines
+918265041513
+918265041513

ABIRAPRO 250

Prostate cancer is one of the most common cancers in men, and advanced cases require effective hormonal therapies to control disease progression. ABIRAPRO 250 Tablets are widely used in the treatment of advanced prostate cancer. At Unnati Pharmax, we specialize in the global export of ABIRAPRO 250 from India, ensuring quality, compliance, and reliable worldwide supply.

This blog provides complete information on ABIRAPRO 250 uses, composition, mechanism of action, dosage, side effects, and export details.


What is ABIRAPRO 250?

ABIRAPRO 250 contains Abiraterone Acetate 250 mg, an androgen biosynthesis inhibitor. It reduces the production of male hormones (androgens) that promote the growth of prostate cancer cells.

Because of its targeted hormonal action, ABIRAPRO 250 is a key medicine in advanced prostate cancer therapy.


Uses of ABIRAPRO 250 Tablets

ABIRAPRO 250 is prescribed for:

  • Metastatic castration-resistant prostate cancer (mCRPC)

  • Metastatic hormone-sensitive prostate cancer

  • Advanced prostate cancer in combination with steroids

  • Patients who have progressed after other treatments

Therefore, ABIRAPRO 250 plays a critical role in prostate cancer management.


How Does ABIRAPRO 250 Work?

ABIRAPRO 250 blocks the CYP17 enzyme involved in androgen production.

As a result:

  • Testosterone levels decrease

  • Cancer cell growth slows

  • Disease progression is controlled

This targeted approach improves survival outcomes in prostate cancer patients.


Dosage and Administration

  • Common dose: 250 mg tablets as prescribed by the oncologist

  • Taken orally on an empty stomach

  • Usually combined with low-dose corticosteroids

⚠️ Important: Dosage and treatment duration must be determined by a specialist.


Possible Side Effects

Some patients may experience:

  • High blood pressure

  • Fluid retention

  • Low potassium levels

  • Fatigue

  • Joint pain

  • Liver enzyme changes

However, regular monitoring helps manage these side effects effectively.


Precautions and Warnings

Before using ABIRAPRO 250, patients should inform their doctor if they have:

  • Liver disease

  • Heart conditions

  • High blood pressure

  • Electrolyte imbalance

  • Plans for pregnancy (partner considerations)

Routine blood tests and blood pressure monitoring are recommended.


Why Choose Unnati Pharmax for ABIRAPRO 250 Export?

Unnati Pharmax is a reliable Indian pharmaceutical exporter, serving international markets with quality-assured oncology medicines.

Our Key Advantages

  • WHO-GMP certified manufacturing sources

  • Competitive export pricing

  • Secure export-standard packaging

  • Complete regulatory documentation

  • Timely global delivery

As a result, global buyers trust Unnati Pharmax for prostate cancer medicine supply.


Global Export of ABIRAPRO 250 Tablets

We export ABIRAPRO 250 to:

  • Africa

  • Middle East

  • Southeast Asia

  • CIS countries

  • Latin America

Additionally, we support buyers with documentation and logistics for smooth import clearance.


Frequently Asked Questions (FAQs)

1. What is ABIRAPRO 250 used for?

ABIRAPRO 250 is used to treat advanced and metastatic prostate cancer.

2. Is ABIRAPRO 250 chemotherapy?

No. ABIRAPRO 250 is a hormonal targeted therapy, not chemotherapy.

3. Can ABIRAPRO 250 be exported from India?

Yes. Unnati Pharmax exports ABIRAPRO 250 with full legal and regulatory compliance.

4. How should ABIRAPRO 250 be stored?

Store at room temperature, away from moisture and direct sunlight.

5. Why buy ABIRAPRO 250 from Unnati Pharmax?

Because we ensure authentic products, export expertise, and reliable global supply.


Conclusion

In conclusion, ABIRAPRO 250 Tablets are an effective and widely used therapy for advanced prostate cancer. Selecting a trusted exporter ensures consistent quality and uninterrupted treatment supply.

Unnati Pharmax is committed to the safe, compliant, and timely export of ABIRAPRO 250 from India, making us a dependable partner for global oncology buyers.PON-8669251513


 2026-01-24T13:00:02

Keywords